# Comparison of NODAT in Kidney Transplant Patients Receiving Belatacept Versus Standard Immunosuppression

> **NCT01875224** · PHASE4 · UNKNOWN · sponsor: **University of Arizona** · enrollment: 32 (estimated)

## Conditions studied

- New Onset Diabetes After Transplant
- Kidney Transplantation

## Interventions

- **DRUG:** Belatacept
- **DRUG:** Tacrolimus

## Key facts

- **NCT ID:** NCT01875224
- **Lead sponsor:** University of Arizona
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-08
- **Primary completion:** 2016-08
- **Final completion:** 2016-08
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2013-06-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01875224

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01875224, "Comparison of NODAT in Kidney Transplant Patients Receiving Belatacept Versus Standard Immunosuppression". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01875224. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*